| As Of | Filing | | Doc. | | Page | | Title | Docs. |
|---|
| | |  |
| 1/29/24 | | DEF 14A | | | | 1 | | Annual Report on Form 10-K | 2 |
| 1/5/24 | | 10-K | | | | 1 | | As of October 31, 2023 and 2022 | 1 |
| 1/29/24 | | DEF 14A | | | | 1 | | Assessment of Compensation-Related Risks | 2 |
| | | | | | 1 | | CEO Pay Ratio Disclosure | 2 |
| | | | | | 1 | | Compensation Discussion and Analysis | 2 |
| | | | | | 1 | | Compensation of Directors | 2 |
| 6/2/23 | | 10-Q | | | | 1 | | Condensed Consolidated Balance Sheets as of April 30, 2023 and October 31, 2022 | 1 |
| 3/8/24 | | 10-Q | | | | 1 | | Condensed Consolidated Balance Sheets as of January 31, 2024 and October 31, 2023 | 1 |
| 9/8/23 | | 10-Q | | | | 1 | | Condensed Consolidated Balance Sheets as of July 31, 2023 and October 31, 2022 | 1 |
| | | | | | 1 | | Condensed Consolidated Statements of Cash Flows Three and Nine Months Ended July 31, 2023 and 2022 | 1 |
| 6/2/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Cash Flows Three and Six Months Ended April 30, 2023 and 2022 | 1 |
| 3/8/24 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Cash Flows Three Months Ended January 31, 2024 and 2023 | 1 |
| 9/8/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Changes in Shareholders' Equity Three and Nine Months Ended July 31, 2023 and 2022 | 1 |
| 6/2/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Changes in Shareholders' Equity Three and Six Months Ended April 30, 2023 and 2022 | 1 |
| 3/8/24 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Changes in Shareholders' Equity Three Months Ended January 31, 2024 and 2023 | 1 |
| 9/8/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Comprehensive Income (Loss) Three and Nine Months Ended July 31, 2023 and 2022 | 1 |
| 6/2/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Comprehensive Income (Loss) Three and Six Months Ended April 30, 2023 and 2022 | 1 |
| 3/8/24 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Comprehensive Income Three Months Ended January 31, 2024 and 2023 | 1 |
| 9/8/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Operations Three and Nine Months Ended July 31, 2023 and 2022 | 1 |
| 6/2/23 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Operations Three and Six Months Ended April 30, 2023 and 2022 | 1 |
| 3/8/24 | | 10-Q | | | | 1 | | Condensed Consolidated Statements of Operations Three Months Ended January 31, 2024 and 2023 | 1 |
| 1/5/24 | | 10-K | | | | 1 | | Consolidated Balance Sheets -- as of October 31, 2023 and 2022 | 1 |
| | | | | | 1 | | Consolidated Statements of Cash Flows -- years ended October 31, 2023, 2022 and 2021 | 1 |
| | | | | | 1 | | Consolidated Statements of Changes in Shareholders' Equity -- years ended October 31, 2023, 2022 and 202 | 1 |
| | | | | | 1 | | Consolidated Statements of Comprehensive Income ( Loss) -- years ended October 31, 2023, 2022 and 2021 | 1 |
| | | | | | 1 | | Consolidated Statements of Op erations -- years ended October 31, 2023, 2022 and 2021 | 1 |
| 3/8/24 | | 10-Q | | | | 1 | | Controls and Procedures | 3 |
| 1/29/24 | | DEF 14A | | | | 1 | | Corporate Governance | 2 |
| | | | | | 1 | | Director Compensation Table | 2 |
| | | | | | 1 | | Equity Compensation Plan Information at 2023 Fiscal Year End | 2 |
| | | | | | 1 | | Executive Compensation | 2 |
| 3/8/24 | | 10-Q | | | | 1 | | Exhibits | 3 |
| | | | | | 1 | | Financial Information | 3 |
| | | | | | 1 | | Financial Statements | 3 |
| 1/29/24 | | DEF 14A | | | | 1 | | Grants of Plan-Based Awards in 2023 Table | 2 |
| | | | | | 1 | | Incorporation by Reference | 2 |
| 3/8/24 | | 10-Q | | | | 1 | | Item 1 | 3 |
| | | | | | 1 | | Item 1A | 3 |
| | | | | | 1 | | Item 2 | 3 |
| | | | | | 1 | | Item 3 | 3 |
| | | | | | 1 | | Item 4 | 3 |
| | | | | | 1 | | Item 5 | 3 |
| | | | | | 1 | | Item 6 | 3 |
| | | | | | 1 | | Legal Proceedings | 3 |
| | | | | | 1 | | Management's Discussion and Analysis of Financial Condition and Results of Operations | 3 |
| | | | | | 1 | | Notes to Condensed Consolidated Financial Statements | 3 |
| 1/5/24 | | 10-K | | | | 1 | | Notes to Consolidated Financial Statements | 1 |
| 1/29/24 | | DEF 14A | | | | 1 | | Option Exercises and Stock Vested in 2023 | 2 |
| | | | | | 1 | | Other Business | 2 |
| 3/8/24 | | 10-Q | | | | 1 | | Other Information | 3 |
| 1/29/24 | | DEF 14A | | | | 1 | | Outstanding Equity Awards at 2023 Fiscal Year End Table | 2 |
| 3/8/24 | | 10-Q | | | | 1 | | Part I -- Financial Information | 3 |
| | | | | | 1 | | Part II -- Other Information | 3 |
| 1/29/24 | | DEF 14A | | | | 1 | | Pay Versus Performance | 2 |
| | | | | | 1 | | Potential Payments upon Termination | 2 |
| | | | | | 1 | | Proposal 1. Election of Directors | 2 |
| | | | | | 1 | | Proposal 2. Advisory Vote to Approve Executive Compensation | 2 |
| | | | | | 1 | | Proposal 3. Proposed Amendments to Articles of Incorporation | 2 |
| | | | | | 1 | | Proposal 4. Ratification of Appointment of Independent Registered Public Accounting Firm | 2 |
| | | | | | 1 | | Proxy Statement | 2 |
| 3/8/24 | | 10-Q | | | | 1 | | Quantitative and Qualitative Disclosures About Market Risk | 3 |
| 1/29/24 | | DEF 14A | | | | 1 | | Questions and Answers About the 2024 Annual Meeting and Voting | 2 |
| 1/5/24 | | 10-K | | | | 1 | | Report of Independent Registered Public Accounting Firm | 1 |
| 1/29/24 | | DEF 14A | | | | 1 | | Report of the Audit Committee | 2 |
| | | | | | 1 | | Report of the Compensation Committee | 2 |
| 3/8/24 | | 10-Q | | | | 1 | | Risk Factors | 3 |
| 1/29/24 | | DEF 14A | | | | 1 | | Security Ownership of Certain Beneficial Owners and Management | 2 |
| | | | | | 1 | | Shareholder Proposals for Our 2025 Annual Meeting | 2 |
| 3/8/24 | | 10-Q | | | | 1 | | Signatures | 3 |
| | | | | | 1 | | Table of Contents | 3 |
| 1/29/24 | | DEF 14A | | | | 1 | | Tabular Compensation Information | 2 |
| 3/8/24 | | 10-Q | | | | 1 | | Unregistered Sales of Equity Securities and Use of Proceeds | 3 |
| 1/5/24 | | 10-K | | | | 1 | | Years ended October 31, 2023, 2022 and 202 | 1 |
| | | | | | 1 | | Years ended October 31, 2023, 2022 and 2021 | 1 |
